The Patent Finder
GG

GBS Global Biopharma, Inc.

First filing 2017
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Four patents currently held, every record listed here

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2038. from the record

Of the 2 now held by other companies, 2 name GB Sciences Inc. as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jan 2038
Next term end
3
Patent families

When these terms end

Each bar runs from grant to computed term end. 2020 to 2039.
US 10,857,107 Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders Jan 31, 2038
US 11,980,592 Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases Apr 9, 2038
US 10,709,670 Myrcene-Containing Complex Mixtures Targeting TRPV1 May 22, 2038
US 10,653,640 Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases Oct 23, 2038
US 11,944,593 Myrcene-Containing Complex Mixtures Targeting TRPV1 Apr 22, 2039
US 11,260,044 TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes May 22, 2039
20242028203220362039
5 pending applications: term is not computable until grant.Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 2, 2027
    The maintenance fee for Myrcene-Containing Complex Mixtures Targeting TRPV1 (US 11,944,593) comes due Oct 2, 2027. Unpaid by Apr 3, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 10,857,107Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders
In force
 · High confidence
In forceHigh confidence
US 10,709,670Myrcene-Containing Complex Mixtures Targeting TRPV1
In force
 · High confidence
In forceHigh confidence
US 11,944,593Myrcene-Containing Complex Mixtures Targeting TRPV1
In force
 · High confidence
In forceHigh confidence
US 11,260,044TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 4: 2 patents in force now held by others · 5 applications pending · 8 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited